Text Messaging and Atopic Dermatitis

Completed · Not applicable

Conditions studied: Atopic Dermatitis

In brief

Atopic dermatitis is a common problem faced by patients of all ages and backgrounds. Treatment regimens and specific therapies may be time consuming and multiple studies have documented a parallel decrease in compliance as time after an office visit increases. The adolescent population is an extremely challenging sub-group of patients in terms of complying with a treatment regimen. Not only are they striving for independence and thus lacking supervision of a regimen by a parent, but their complex thinking skills are immature, leading to forgetful behavior. By introducing a reminder system for these vulnerable patients that is easily incorporated into their daily lives, the investigators propose that patients will have better compliance at applying their medication and thus improving their atopic dermatitis. Text-messaging via cell phones has become very popular among teenagers and adults and provides a non-obtrusive method of sending a treatment reminder.

Key facts

Study ID

NCT01216059

Run by

Northwestern University

People needed

26

Starts

2010-10-01

Expected to finish

2012-06-01

Last updated by the study team

2012-12-03

Who can join

Age: 10 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 10-17 inclusive
• Capable of giving informed consent/assent. Of note, all subjects will sign an assent form and parents will sign a parent consent form.
• Diagnosed with Atopic Dermatitis by a physician (self report)
• IGA score fo 2 or greater
• Currently using at least one prescribed topical therapy for atopic dermatitis
• Have a mobile phone capable of receiving text messages
• Able to retrieve text messages from mobile phone
• Able to adhere to study visit schedule and other protocol requirements.

You may not qualify if…

• Younger than 10 years of age or 18 years and older at the time of enrollment
• No diagnosis of atopic dermatitis by a physician
• IGA score of 0 or 1
• Currently on no prescribed topical treatment for atopic dermatitis
• UV therapy or climatotherapy is a part of treatment for atopic dermatitis
• Does not have a mobile phone capable of receiving text messages
• Unable to retrieve text message
• Non-English speaking individuals (text messages are in English)

Where it is running

• Northwestern University Feinberg School of Medicine, Department of Dermatology — Chicago, Illinois, United States
• Children's Memorial Hospital — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.